Dr. N. Muruganandam
Research Profile
Dr. N. Muruganandam is a public health microbiologist and AcSiR Faculty with expertise in emerging infectious diseases, medical virology, medical bacteriology, immunology, molecular diagnostics, kit development, and biosafety laboratory systems. His research is particularly focused on infectious diseases affecting the Andaman and Nicobar Islands, remote and far-flung populations, and tribal communities, while also extending to mainland India.
Starting his career as a Tutor at A V Medical College, Pondicherry, his research has evolved from diagnostic virology and chikungunya research to multidisciplinary investigations encompassing respiratory viral infections, leptospirosis, sexually transmitted infections, genomic surveillance, and point-of-care diagnostics.
Scientific Contributions
Island-Specific Epidemiology & Surveillance
Developed island-specific evidence on infectious diseases through molecular and epidemiological studies. He served as a frontline diagnostic warrior during the COVID-19 and H1N1 pandemics, and successfully investigated multiple viral outbreaks across the islands including Chikungunya, Dengue, Zika, and HFMD among tribal and non-tribal populations.
Diagnostic Technologies & IPR Innovation
Translated research into tangible diagnostic innovations for resource-constrained settings, holding multiple registered patents and design developments. These explicitly include the VCHARI and PVCHARI portable immunoassay devices, and the MUNISH microscope image stabilizing holder.
Public Health Interventions & Vaccination
Contributed substantially to pathogen characterization and public health policy. His research findings directly led to active formulation of vaccination strategies, including the pivotal recommendation to include the HPV vaccine in the universal immunization program of the islands, and initiating the immunization of the particularly vulnerable Jarawa tribe.
Biosafety & Laboratory Capacity Building
Contributed to national laboratory capacity building, including training programmes in leptospirosis diagnosis and COVID-19-related laboratory science. He actively provides expert input and consultation for BSL-2 and BSL-3 laboratory design across India, including for JIPMER, ICMR-NITM, and ICMR-RMRC.
Current Focus & Significance
His current portfolio is centerd on strengthening infectious disease preparedness and diagnostic capacity in the Andaman and Nicobar Islands. Major ongoing areas include managing the State Level Viral Diagnostic and Research Laboratory (2024), Influenza and COVID-19 surveillance through the DHR-ICMR VRDL network, and leading the multicentric ICMR Taskforce on Establishment of Reference Intervals (TERIIP) for the Indian Population (2025).
His work addresses the distinctive challenges of infectious disease surveillance in geographically isolated settings by connecting scientific investigation directly to public-health action. Characterized by a strong translational orientation—from pathogen discovery to diagnostic innovation and workforce capacity building—his research contributes to building a resilient infectious-disease surveillance ecosystem for far-flung island populations.
Ph.D. Students Trained
Dedicated to rigorous academic mentorship and institutional capacity building in biomedical sciences, guiding scholars from prestigious universities across the nation.